WAVE Life Sciences (WVE) Misses Q4 EPS by 6c

WAVE Life Sciences (NASDAQ: WVE) reported Q4 EPS of ($0.47), $0.06 worse than the analyst estimate of ($0.41). Revenue for the quarter came in at $1.24 million versus the consensus estimate of $7.06 million.

For earnings history and earnings-related data on WAVE Life Sciences (WVE) click here.

You May Also Be Interested In

• Sprinklr (CXM) Tops Q2 EPS by 1c, Offers Guidance
• Scotiabank Starts Block Inc. (XYZ) at Sector Perform
• EVI Industries acquires Sudsies, launches garment care division